International Immunology Advance Access published online on September 26, 2005
International Immunology, doi:10.1093/intimm/dxh327
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pathology, University of Utah School of Medicine, 50 N Medical Drive, Salt Lake City, UT 84132, USA
* To whom correspondence should be addressed. The microphthalmic (mi) mouse exhibits deficiencies in the development of osteoclasts, melanocytes, mast cells and marrow B cells. Previously, we demonstrated that the marrow of such mice over-express receptor activator of nuclear factor
Received January 14, 2005
Accepted August 26, 2005
Article
Partial rescue of B cells in microphthalmic osteopetrotic marrow by loss of response to type I IFNs
2 Department of Medicine, University of Utah School of Medicine, 50 N Medical Drive, Salt Lake City, UT 84132, USA
John H. Weis, E-mail: john.weis{at}path.utah.edu
![]()
Abstract
B (RANK) ligand (RANKL). RANKL has been shown to induce the production of IFN-
, a type I IFN. Additionally, maturing B cells have been shown to undergo apoptosis in response to type I IFNs including IFN-
during differentiation. We hypothesized that the loss of B cells in the marrow of mi mice was due to the over-expression of IFN-
as a result of heightened RANK-RANKL signaling. Creating a mouse with the mi genotype that was non-responsive to IFN-
(lacking the type I IFNR) allowed us to test this hypothesis. These mice demonstrated an elevated number of marrow B cells and marrow precursor cells compared with mi animals possessing the type I IFNR. Intriguingly, type I IFNR-deficient wild-type animals also demonstrated an increased number of precursor cells in the marrow, but not an expansion of B220-positive pre-B cells, compared with wild type, suggesting that modulation of type I IFN responses directly controls the development of marrow constituents.![]()
CiteULike
Connotea
Del.icio.us What's this?